International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Treatment of multiple myeloma has substantially changed over the past decade with the introduction of several classes of new effective drugs that have greatly improved the rates and depth of response. Response criteria in multiple myeloma were developed to use serum and urine assessment of monoclona...

Full description

Saved in:

Bibliographic Details
Published in:	The lancet oncology Vol. 17; no. 8; pp. e328 - e346
Main Authors:	Kumar, Shaji, Paiva, Bruno, Anderson, Kenneth C, Durie, Brian, Landgren, Ola, Moreau, Philippe, Munshi, Nikhil, Lonial, Sagar, Bladé, Joan, Mateos, Maria-Victoria, Dimopoulos, Meletios, Kastritis, Efstathios, Boccadoro, Mario, Orlowski, Robert, Goldschmidt, Hartmut, Spencer, Andrew, Hou, Jian, Chng, Wee Joo, Usmani, Saad Z, Zamagni, Elena, Shimizu, Kazuyuki, Jagannath, Sundar, Johnsen, Hans E, Terpos, Evangelos, Reiman, Anthony, Kyle, Robert A, Sonneveld, Pieter, Richardson, Paul G, McCarthy, Philip, Ludwig, Heinz, Chen, Wenming, Cavo, Michele, Harousseau, Jean-Luc, Lentzsch, Suzanne, Hillengass, Jens, Palumbo, Antonio, Orfao, Alberto, Rajkumar, S Vincent, Miguel, Jesus San, Avet-Loiseau, Herve
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.08.2016 Elsevier Limited
Subjects:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Biopsy Bone marrow Consensus Flow cytometry Hematology, Oncology and Palliative Medicine Humans Immunoglobulins Methods Multiple myeloma Multiple Myeloma - drug therapy Neoplasm, Residual - chemically induced Neoplasm, Residual - diagnosis Practice Guidelines as Topic - standards Proteins Transplants & implants Urine Working groups
ISSN:	1470-2045, 1474-5488, 1474-5488
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!